Evaluation of the potential of triethanolamine to alter hepatic choline levels in female B6C3F1 mice
- PMID: 15056812
- PMCID: PMC1592523
- DOI: 10.1093/toxsci/kfh115
Evaluation of the potential of triethanolamine to alter hepatic choline levels in female B6C3F1 mice
Abstract
Triethanolamine (TEA), a widely used nongenotoxic alcohol-amine, has recently been reported to cause an increased incidence of liver tumors in female B6C3F1 mice, but not in males nor in Fischer 344 rats. Choline deficiency induces liver cancer in rodents, and TEA could compete with choline uptake into tissues. The potential of TEA to cause choline deficiency in the liver of these mice as a mode of tumorigenesis was investigated. Groups of female B6C3F1 mice were administered 0 (vehicle) or a maximum tolerated dosage (MTD) of 1000 mg/kg/day TEA (Trial I) and 0, 10, 100, 300, or 1000 mg/kg/day TEA (Trial II) in acetone vehicle via skin painting 5 days/week for 3 weeks. Female CDF(R) rats were also administered 0 or an MTD dosage of 250 mg/kg/day TEA (Trial II) in a similar manner. No clinical signs of toxicity were noted, and upon sacrifice, levels of hepatic choline, its primary storage form, phosphocholine (PCho), and its primary oxidation product, betaine, were determined. A statistically significant decrease in PCho and betaine, was observed at the high dosage (26-42%) relative to controls and a dose-related, albeit variable, decrease was noted in PCho levels. Choline levels were also decreased 13-35% at the high dose level in mice. No changes in levels of choline or metabolites were noted in treated rats. A subsequent evaluation of the potential of TEA to inhibit the uptake of (3)H-choline by cultured Chinese Hamster Ovary Cells revealed a dose-related effect upon uptake. It was concluded that TEA may cause liver tumors in mice via a choline-depletion mode of action and that this effect is likely caused by the inhibition of choline uptake by cells.
Figures
Similar articles
-
Diethanolamine induces hepatic choline deficiency in mice.Toxicol Sci. 2002 May;67(1):38-45. doi: 10.1093/toxsci/67.1.38. Toxicol Sci. 2002. PMID: 11961214
-
NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies).Natl Toxicol Program Tech Rep Ser. 1999 Nov;449:1-298. Natl Toxicol Program Tech Rep Ser. 1999. PMID: 12594526
-
Toxicology and carcinogenesis studies of coconut oil acid diethanolamine condensate (CAS No. 68603-42-9) in F344/N rats and B6C3F1 mice (dermal studies).Natl Toxicol Program Tech Rep Ser. 2001 Jan;479:5-226. Natl Toxicol Program Tech Rep Ser. 2001. PMID: 12571684
-
Review of the carcinogenic activity of diethanolamine and evidence of choline deficiency as a plausible mode of action.Regul Toxicol Pharmacol. 2005 Dec;43(3):260-71. doi: 10.1016/j.yrtph.2005.08.001. Epub 2005 Sep 26. Regul Toxicol Pharmacol. 2005. PMID: 16188361 Review.
-
Toxicology of mono-, di-, and triethanolamine.Rev Environ Contam Toxicol. 1997;149:1-86. doi: 10.1007/978-1-4612-2272-9_1. Rev Environ Contam Toxicol. 1997. PMID: 8956558 Review.
Cited by
-
Diethanolamine alters neurogenesis and induces apoptosis in fetal mouse hippocampus.FASEB J. 2006 Aug;20(10):1635-40. doi: 10.1096/fj.06-5978com. FASEB J. 2006. PMID: 16873886 Free PMC article.
References
-
- Barbee SJ, Hartung R. The effect of diethanolamine on hepatic and renal phospholipid metabolism in the rat. Toxicol Appl Pharmacol. 1979;47:421–430. - PubMed
-
- Borman LS. Modulation of mammalian cell growth by a choline analog, N-isopropylethanoamine. In Vitro. 1982;18:129–140. - PubMed
-
- Kamendulis LM, Smith DJ, Jiao Z, Klaunig JE. Species differences in the induction of hepatocellular DNA synthesis by diethanolamine. The Toxicol. 200372 Abstr. No. 1155. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources